Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SSCleveland
    Registered Vendor
    • Feb 2017
    • 2

    #1

    Associate Director, Oncology & Immunology Bioinformatics opportunity w/Thermo Fisher

    Are you passionate about next-generation sequencing (NGS) and enabling precision genomics? We have an opening for an outstanding scientist to lead projects to develop next-generation DNA sequencing assays for Immunotherapy with a particular focus on Oncology. This individual will lead R&D efforts to develop products and establish collaborations with leading academic and pharma partners. The successful candidate will be part of an innovative multi-disciplinary team developing applications for Ion Torrent DNA sequencing. As part of this team, they will be expected to work in a fast paced, complex setting to hard deliverables in a collaborative environment. Critical thinking, determination to succeed, the willingness and courage to push the boundaries on the possible and the drive to deliver are key attributes. The candidate will lead a small team (an individual contributor role is also an option if preferred), and will provide scientific guidance, prioritization, manage deliverables and product development milestones to develop relevant assays and informatics solutions, will collaborate closely with the business partners on strategy, and will establish and maintain collaborations for conference presentations and/or publication.

    Primary responsibilities include:
    • Lead large multi-disciplinary teams developing assays in the immunotherapy space
    • Directly manage a small team of bioinformatics scientists
    • Ensure successful launch of products from conception, innovation through product development and validation.
    • Work with leadership to establish and refine strategy and priorities
    • Identify, establish, nurture and complete collaborations with leading researchers
    • Present at conferences, publish white papers and/or scientific papers

    Requirements:
    • PhD in Bioinformatics, Computational Biology, Computer Science, Immunology, Molecular Biology, or similar. MS and equivalent experience will be considered.
    • Experience with multiple complete product development life cycles from concept to development and product testing and final release. Demonstrated ability to lead complex multi-disciplinary products and successfully deliver results.
    • Demonstrated scientific background in oncology or immunology, ideally both, as shown by publications, patents, or product development.
    • An excellent understanding of genomics, molecular biology, and common biological techniques like PCR and next-generation sequencing.
    • Previous experience in a Pharma or Biotech company a major advantage. Understands drug development, biomarkers, and companion diagnostics.
    • Previous experience leading a team is a major plus.
    • Excellent communication and organization skills.
    • Experience with developing next-generation sequencing assays and/or analysis tools, good data mining skills.
    • Strong general bioinformatics skills. Hands-on experience with sequence analysis tools (e.g. Blast, bowtie, etc.) and excellent understanding of genomic databases and their annotations (GenBank, RefSeq, ENSEMBL, dbSNP, UCSC genome browser).
    • Prefer a proven track record on successfully developed bioinformatics related commercial software products.
    •Prefer experience with cloud computing, parallel computing and big data.

    Should you be interested, please forward a copy of your resume and I will be sure to contact immediately.
    Susan Cleveland
    Sr Recruiter
    Thermo Fisher Scientific
    [email protected]

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...